| Extremely low frequency electromagnetic fields facilitate vesicle endocytosis by increasing presynaptic calcium channel expression at a central synapse Z Sun, J Ge, B Guo, J Guo, M Hao, Y Wu, Y Lin, T La, P Yao, Y Mei, ... Scientific reports 6 (1), 1-11, 2016 | 80 | 2016 |
| Amygdala and anterior cingulate transcriptomes from individuals with bipolar disorder reveal downregulated neuroimmune and synaptic pathways PP Zandi, AE Jaffe, FS Goes, EE Burke, L Collado-Torres, L Huuki-Myers, ... Nature neuroscience 25 (3), 381-389, 2022 | 47 | 2022 |
| Trends in prescriptions of lithium and other medications for patients with bipolar disorder in office-based practices in the United States: 1996–2015 Y Lin, R Mojtabai, FS Goes, PP Zandi Journal of Affective Disorders 276, 883-889, 2020 | 32 | 2020 |
| Clinical predictors of non‐response to lithium treatment in the Pharmacogenomics of Bipolar Disorder (PGBD) study Y Lin, AX Maihofer, E Stapp, M Ritchey, N Alliey‐Rodriguez, A Anand, ... Bipolar disorders 23 (8), 821-831, 2021 | 30 | 2021 |
| Genes as a source of risk for mental disorders. PP Zandi, HC Wilcox, Y Lin, B Maher, MD Fallin Oxford University Press, 2019 | 2 | 2019 |
| Incidence and Costs of Clinically Significant Events with Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study DJ Simmons, SJ Valerio, DS Thomas, MJ Healey, Z Jiang, ... Advances in Therapy, 1-17, 2024 | 1 | 2024 |
| Identification of characteristics predictive of long-term survival with durvalumab or durvalumab plus tremelimumab in metastatic urothelial carcinoma M Alt, C Stecca, Y Lin, G Kazeem, ET Goluboff, SS Sridhar BMC cancer 23 (1), 1-10, 2023 | 1 | 2023 |
| Treatment Patterns and Outcomes in Patients with Advanced Biliary Tract Cancers Treated with Gemcitabine-Based Chemotherapy: A Retrospective Study F Dayyani, HA Stirnadel-Farrant, J Hu, Y Lin, N Kebede, SJ Valerio, ... Cancers 17 (2), 305, 2025 | | 2025 |
| 1325P TRIDENT: Machine learning (ML) multimodal signatures to identify patients that would benefit most from tremelimumab (T) addition to durvalumab (D)+ chemotherapy (CT) with … F Skoulidis, S Jabbour, EB Garon, P Iyengar, G Scagliotti, L Ferrer, ... Annals of Oncology 35, S842-S843, 2024 | | 2024 |
| Treatment patterns of gemcitabine-based chemotherapy in patients with de novo and recurrent advanced biliary tract cancer. F Dayyani, HA Stirnadel-Farrant, J Hu, Y Lin, N Kebede, SJ Valerio, ... Journal of Clinical Oncology 42 (3_suppl), 454-454, 2024 | | 2024 |
| P1. 25-09 TARGET: A Phase II Study of 5-year Adjuvant Osimertinib in Completely Resected EGFR-mutated Stage II-IIIB NSCLC R Soo, F De Marinis, JY Han, CMJ Ho, Y Lin, L Servidio, M Sandelin, ... Journal of Thoracic Oncology 18 (11), S272, 2023 | | 2023 |
| Incidence and costs associated with clinically significant events in real-world patients with unresectable hepatocellular carcinoma on systemic therapy. M Healey, D Simmons, SJ Valerio, J Sah, D Pierce, Z Jiang, D Thomas, ... Journal of Clinical Oncology 41 (4_suppl), 514-514, 2023 | | 2023 |
| Methylomic and transcriptomic predictors of one-month exposure to cortisol in healthy individuals RS Lee, PP Zandi, Y Lin, F Seifuddin, KS Benke, ME McCaul, K Reitz, ... Stress 24 (6), 840-848, 2021 | | 2021 |
| Genes as a Source of Risk for Mental Disorders PPZHC WILCOX, Y LIN, B MAHER, MD FALLIN Public Mental Health, 223, 2019 | | 2019 |
